|4Jan 8, 4:31 PM ET

Donohue James J. 4

4 · Acurx Pharmaceuticals, Inc. · Filed Jan 8, 2025

Insider Transaction Report

Form 4
Period: 2025-01-06
Transactions
  • Purchase

    Common Stock

    2025-01-06$1.01/sh+9,852$10,00022,352 total
  • Purchase

    Warrants for Common Stock

    2025-01-06+9,8529,852 total
    Exercise: $0.90From: 2025-01-07Exp: 2030-01-07Common Stock (9,852 underlying)
Footnotes (2)
  • [F1]Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
  • [F2]Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.

Documents

1 file
  • 4
    tm252665-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT